More than 161 dialysis lawsuit claims alleging cardiovascular injuries and death from GranuFlo and NaturaLyte are pending in a federal litigation underway in the District of Massachusetts, according to a recent statistics report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML).

The MDL Statistics Report, dated May 14th, 2013 was released approximately two months after the multidistrict litigation for claims involving the dialysis drugs was created in Massachusetts federal court and almost a year after they were subject to a Class I recall by the U.S. Food and Drug Administration (FDA).

In June 2012, the two medications used to neutralize the acid that builds up during dialysis treatments were recalled by the agency determined the side effects to be serious and potentially life-threatening.

GranuFlo Lawsuit Side Effects

The following injuries have been named in GranuFlo lawsuits: • cardiovascular death • sudden cardiac death • heart attack • cardiopulmonary arrest • other catastrophic heart injuries

Dialysis lawsuits involving GranuFlo and NaturaLyte, which were distributed at more than 125,000 clinics operated by Fresenius Medical, allege the manufacturer failed to warn consumers about the dangers of their dialysis drugs prior to the recall. Fresenius operates more than 1,800 kidney clinics in the U.S., and treats more than a third of the country’s dialysis patients.

There is also controversy over whether Fresenius waited too long to issue its “Urgent Product Notification” on March 29th, 2012, which warned patients of the heart risks associated with NaturaLyte and GranuFlo.

According to dialysis lawsuits, Fresenius sent an internal memo in November 2011 alerting physicians of more than 900 patient deaths that had resulted in patients who took the drugs. In the e-mail, doctors were advised to adjust their dosages of GranuFlo and NaturaLyte, as cardiovascular side effects may turn fatal for patients with high levels of bicarbonate in their blood. Fresenius’ medical staff found these patients to be six times more likely to suffer cardiac arrest than those with lower levels.

The FDA received a copy of this internal memo from an anonymous source prior to issuing the GranuFlo recall in June.

File a Dialysis Lawsuit on Behalf of a Loved One

If your loved one suffered cardiovascular injuries or even death after they were given GranuFlo or NaturaLyte, the time is now to file a dialysis lawsuit with an attorney at Bernstein Liebhard LLP. Call the Firm directly to learn more about your legal rights at (877) 779-1414.

Published June 17, 2013 by